Who owns the LogoMark trademark?

The LogoMark trademark is owned by Telix Pharmaceuticals Limited.

What is the serial number for LogoMark?

The USPTO serial number for LogoMark is 79414435.

What is the registration number for LogoMark?

LogoMark is registered under USPTO registration number 8064102.

LOG

USPTO Trademark Record

REGISTERED

LogoMark

Q: What class is the LogoMark trademark registered in?

The LogoMark trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 010 (Surgical, medical, dental & veterinary apparatus).

SN 79414435·Reg 8064102·Filed Aug 02, 2024

Owner Telix Pharmaceuticals Limited

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, eyes and teeth; spectacles, contact lenses and sunglasses; orthopaedic articles; suture materials; therapeutic and assistive devices adapted for persons with disabilities; massage apparatus; apparatus, devices and articles for nursing infants; sexual activity apparatus, devices and articles.

LogoMark (Serial No. 79414435), Registration No. 8064102, is a registered US trademark filed on Aug 02, 2024 by Telix Pharmaceuticals Limited. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 010 (Surgical, medical, dental & veterinary apparatus).

early section 8: December 16, 2031

Mark Intelligence

LogoMark (Reg. #8064102) is a registered US trademark that has been protecting its owner, Telix Pharmaceuticals Limited, since 2024. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 010 (Surgical, medical, dental & veterinary apparatus) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 4 opposition proceedings during prosecution.

FILED

Aug 02, 2024

SERIAL

79414435

REG#

8064102

REGISTERED

Dec 16, 2025

Owner

Applicant

Telix Pharmaceuticals Limited

Entity

Not Provided

Address

Suite 401, 55 Flemington Road

Country

Attorney

NameAndrew S. Ehard

Law firm

Andrew S. Ehard Merchant & Gould, P.C.

Address

P.O. Box 2910, Minneapolis, MN 55402, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateAug 02, 2024

Serial Number79414435

Registration No.8064102

Registration DateDec 16, 2025

Status DateDec 16, 2025

Published for OppositionOct 28, 2025

Mark TypeDesign only

Status DescriptionLive and registered

Filing Signals

FILED

2024

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 4× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 010Surgical, medical, dental & veterinary apparatus

US codes: 026, 039, 044

Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, eyes and teeth; spectacles, contact lenses and sunglasses; orthopaedic articles; suture materials; therapeutic and assistive devices adapted for persons with disabilities; massage apparatus; apparatus, devices and articles for nursing infants; sexual activity apparatus, devices and articles.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

29 events

NEW REPRESENTATIVE AT IB RECEIVED

Jul 30, 2026

NEW REPRESENTATIVE AT IB RECEIVED

FINAL DECISION TRANSACTION PROCESSED BY IB

Jul 16, 2026

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Jun 27, 2026

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Jun 27, 2026

FINAL DISPOSITION NOTICE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Jun 25, 2026

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Jun 08, 2026

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Jun 08, 2026

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Mar 16, 2026

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

NEW REPRESENTATIVE AT IB RECEIVED

Jan 22, 2026

NEW REPRESENTATIVE AT IB RECEIVED

Jan 01, 2026

NEW REPRESENTATIVE AT IB RECEIVED

REGISTERED-PRINCIPAL REGISTER

Dec 16, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Dec 16, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Oct 28, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 28, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 22, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 25, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 25, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 25, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 25, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

REFUSAL PROCESSED BY IB

Apr 19, 2025

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Apr 01, 2025

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Apr 01, 2025

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Feb 25, 2025

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Feb 24, 2025

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Feb 10, 2025

ASSIGNED TO EXAMINER

LIMITATION FROM ORIGINAL APPLICATION ENTERED

Jan 23, 2025

LIMITATION FROM ORIGINAL APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 23, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

Jan 23, 2025

APPLICATION FILING RECEIPT MAILED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Jan 09, 2025

SN ASSIGNED FOR SECT 66A APPL FROM IB

LogoMark

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Telix Pharmaceuticals Limited

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Andrew S. Ehard

Resources

Company